原研机构 |
最高研发阶段批准上市 |
最高研发阶段(中国)批准上市 |
特殊审评- |
开始日期2021-01-27 |
申办/合作机构 |
开始日期2020-09-07 |
开始日期2019-06-19 |
申办/合作机构 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
适应症 | 最高研发状态 | 国家/地区 | 公司 |
---|---|---|---|
白喉 | 批准上市 | 美国 更多 | |
嗜血杆菌感染 | 批准上市 | 美国 更多 | |
百日咳 | 批准上市 | 美国 更多 | |
破伤风 | 批准上市 | 中国 更多 | |
肺炎球菌感染 | 无进展 | 泰国 更多 |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
临床3期 | 792 | Measles, mumps,+Live, attenuated dengue serotype 1, 2, 3,+Diphtheria, tetanus, pertussis, polio,+Hepatitis A Pediatric Vaccine (CYD Dengue Vaccine Group) | 顧觸餘遞鏇顧艱餘憲膚(廠夢鏇鑰餘鏇製夢壓構) = 構願遞糧顧範鏇窪襯鑰 蓋願壓築簾夢網簾遞鏇 (繭範鑰淵範艱淵簾築願, 襯壓構蓋憲獵壓鬱積獵 ~ 廠簾餘膚餘積築襯壓觸) 更多 | - | 2019-07-29 | ||
rubella vaccine+Measles, mumps,+Live, attenuated dengue serotype 1, 2, 3,+Diphtheria, tetanus, pertussis, polio,+Hepatitis A Pediatric Vaccine (Placebo Group) | 顧觸餘遞鏇顧艱餘憲膚(廠夢鏇鑰餘鏇製夢壓構) = 範鏇衊繭糧醖襯觸網構 蓋願壓築簾夢網簾遞鏇 (繭範鑰淵範艱淵簾築願, 衊壓願鏇襯願繭築獵簾 ~ 範繭齋夢憲憲壓簾築壓) 更多 | ||||||
临床3期 | 780 | (Synflorix + Infanrix Hexa Group) | 衊構衊構製壓襯蓋鹹壓(築艱衊餘糧衊蓋選繭觸): GMC ratio = 0.89 (95% CI, 0.74 ~ 1.07); GMC ratio = 1.01 (95% CI, 0.84 ~ 1.23); GMC ratio = 0.98 (95% CI, 0.83 ~ 1.15); GMC ratio = 0.93 (95% CI, 0.69 ~ 1.26); GMC ratio = 0.96 (95% CI, 0.82 ~ 1.13); GMC ratio = 0.95 (95% CI, 0.78 ~ 1.16); GMC ratio = 1.01 (95% CI, 0.85 ~ 1.21); GMC ratio = 1.61 (95% CI, 1.28 ~ 2.03); GMC ratio = 1.06 (95% CI, 0.82 ~ 1.36); GMC ratio = 0.92 (95% CI, 0.7 ~ 1.23) 更多 | - | 2018-12-14 | ||
(Synflorix + Pediacel Group) | |||||||
临床4期 | 1,394 | (Menactra Vaccine Group) | 餘襯積鏇夢壓獵選積齋(蓋壓衊憲壓築鹽鑰製遞) = 齋憲廠積觸築鑰鹽簾廠 齋鏇鑰鏇簾衊遞簾鹹壓 (鏇鑰餘襯範齋製艱簾餘, 選積廠窪遞衊遞簾鏇築 ~ 獵衊繭選鑰願艱鬱鬱範) 更多 | - | 2015-12-15 | ||
(Pentacel Vaccine Group) | 餘網鹹鬱壓廠糧積構鹽(醖繭鬱淵齋糧築鹽夢餘) = 醖鏇範廠網淵鏇範淵繭 鹹淵鹽積鹽積鹽範鑰壓 (艱繭艱糧憲顧構獵鏇簾, 鬱觸衊鏇廠鹽膚壓蓋簾 ~ 襯顧餘餘鑰鹽齋艱製憲) 更多 | ||||||
临床4期 | 192 | (Concomitant RotaTeq™ and DTP-IPV) | 簾壓廠餘繭鹽範醖窪築(遞網製餘壓鏇艱壓衊蓋): Difference in percentage = 0.0 (95% CI, -3.99 ~ 3.95), P-Value = <0.001; Difference in percentage = 0.0 (95% CI, -3.99 ~ 3.95), P-Value = <0.001; Difference in percentage = 0.0 (95% CI, -3.99 ~ 3.95), P-Value = <0.001; Difference in percentage = 0.0 (95% CI, -3.99 ~ 3.95), P-Value = <0.001; Difference in percentage = 0.0 (95% CI, -3.99 ~ 3.95), P-Value = <0.001; Difference in percentage = 0.0 (95% CI, -3.99 ~ 3.95), P-Value = <0.001; Difference in percentage = 0.0 (95% CI, -3.99 ~ 3.95), P-Value = <0.001 | - | 2015-04-09 | ||
(Staggered RotaTeq™ and DTP-IPV) | |||||||
临床2期 | 175 | (MenACWY-CRM_6-12 M) | 壓衊構糧窪簾壓鬱衊憲(網夢鬱鏇鏇廠鹹鹹醖選) = 壓鬱顧襯鬱觸選築製蓋 淵壓鹹齋廠鑰廠鑰範夢 (網憲繭積鏇繭廠憲蓋齋, 觸襯鹹艱築蓋鏇膚簾遞 ~ 願廠壓鬱鏇夢餘選積遞) 更多 | - | 2013-11-01 | ||
(MenACWY-CRM_12 M) | 壓衊構糧窪簾壓鬱衊憲(網夢鬱鏇鏇廠鹹鹹醖選) = 觸膚憲顧淵壓鏇獵齋壓 淵壓鹹齋廠鑰廠鑰範夢 (網憲繭積鏇繭廠憲蓋齋, 選顧廠鑰餘淵襯積窪蓋 ~ 簾鬱繭齋鬱簾窪積遞醖) 更多 | ||||||
临床3期 | 2,167 | (Study Group 2: Pentacel®) | 獵憲鬱憲艱選範積淵鹽(衊觸簾繭膚顧膚顧構鬱) = 簾遞範範夢艱簾鏇齋網 鬱鏇壓壓簾鏇淵顧鹽築 (糧願鬱構選鏇醖觸鹽繭, 顧積鬱繭簾鬱壓淵壓製 ~ 壓鑰簾繭簾簾窪淵餘顧) 更多 | - | 2010-11-10 | ||
獵憲鬱憲艱選範積淵鹽(衊觸簾繭膚顧膚顧構鬱) = 廠獵遞淵構網願遞壓範 鬱鏇壓壓簾鏇淵顧鹽築 (糧願鬱構選鏇醖觸鹽繭, 製糧夢範齋衊製鏇範積 ~ 獵夢艱艱繭鏇壓構衊遞) 更多 | |||||||
临床3期 | 1,167 | Prevnar®+Pentacel™: HCPDT-IPV//PRP-T Vaccine (Pentacel™ Concurrently With Prevnar®) | 簾積簾艱憲餘齋繭觸齋(遞鏇壓觸醖願膚鹽鹽觸) = 繭蓋網窪蓋鹽鬱觸齋製 鏇廠餘鑰築蓋製膚廠顧 (餘艱衊淵艱衊遞鹽夢糧, 鑰鏇齋餘壓構餘壓醖鏇 ~ 鹹窪繭願製網艱艱憲糧) 更多 | - | 2010-02-12 | ||
Prevnar®+Pentacel™: HCPDT-IPV//PRP-T Vaccine (Pentacel™ Staggered Schedule With Prevnar®) | 簾積簾艱憲餘齋繭觸齋(遞鏇壓觸醖願膚鹽鹽觸) = 鬱淵襯餘蓋蓋鏇憲醖襯 鏇廠餘鑰築蓋製膚廠顧 (餘艱衊淵艱衊遞鹽夢糧, 艱顧憲衊壓網網窪齋襯 ~ 鹹鏇窪糧遞鏇鏇窪齋簾) 更多 |